And They’re Off! CAR T Cells Race Toward Market – Medscape
Medscape |
And They're Off! CAR T Cells Race Toward Market
Medscape As previously reported by Medscape Medical News, CAR T cells have shown tremendous results in clinical trials in patients with relapsed/refractory hematologic cancers, who have few — if any — therapeutic options. In some cases, one dose of the … |
